15-51058044-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001311175.2(TNFAIP8L3):c.452G>A(p.Arg151Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000496 in 1,614,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00019 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000035 ( 0 hom. )
Consequence
TNFAIP8L3
NM_001311175.2 missense
NM_001311175.2 missense
Scores
6
13
Clinical Significance
Conservation
PhyloP100: 4.89
Genes affected
TNFAIP8L3 (HGNC:20620): (TNF alpha induced protein 8 like 3) Predicted to enable phosphatidylinositol binding activity and phosphatidylinositol transfer activity. Predicted to be involved in several processes, including inositol lipid-mediated signaling; positive regulation of intracellular signal transduction; and positive regulation of phosphatidylinositol 3-kinase activity. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.09054026).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TNFAIP8L3 | NM_001311175.2 | c.452G>A | p.Arg151Gln | missense_variant | 2/2 | ENST00000637513.2 | |
MIR4713HG | NR_146310.1 | n.194+20363C>T | intron_variant, non_coding_transcript_variant | ||||
TNFAIP8L3 | NM_207381.4 | c.716G>A | p.Arg239Gln | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TNFAIP8L3 | ENST00000637513.2 | c.452G>A | p.Arg151Gln | missense_variant | 2/2 | 1 | NM_001311175.2 | P1 | |
TNFAIP8L3 | ENST00000327536.5 | c.716G>A | p.Arg239Gln | missense_variant | 3/3 | 1 | |||
MIR4713HG | ENST00000559909.1 | n.194+20363C>T | intron_variant, non_coding_transcript_variant | 4 | |||||
TNFAIP8L3 | ENST00000649177.1 | c.314G>A | p.Arg105Gln | missense_variant | 2/2 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152146Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
30
AN:
152146
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000876 AC: 22AN: 251162Hom.: 0 AF XY: 0.0000958 AC XY: 13AN XY: 135736
GnomAD3 exomes
AF:
AC:
22
AN:
251162
Hom.:
AF XY:
AC XY:
13
AN XY:
135736
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461808Hom.: 0 Cov.: 31 AF XY: 0.0000399 AC XY: 29AN XY: 727202
GnomAD4 exome
AF:
AC:
51
AN:
1461808
Hom.:
Cov.:
31
AF XY:
AC XY:
29
AN XY:
727202
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000190 AC: 29AN: 152264Hom.: 0 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74444
GnomAD4 genome
AF:
AC:
29
AN:
152264
Hom.:
Cov.:
32
AF XY:
AC XY:
15
AN XY:
74444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
11
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.716G>A (p.R239Q) alteration is located in exon 3 (coding exon 3) of the TNFAIP8L3 gene. This alteration results from a G to A substitution at nucleotide position 716, causing the arginine (R) at amino acid position 239 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
MutationTaster
Benign
D
PrimateAI
Benign
T
PROVEAN
Uncertain
D;.
REVEL
Benign
Sift
Benign
T;.
Sift4G
Benign
T;.
Polyphen
P;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at